General Information of the Compound
| Compound ID |
CP0042262
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+/-)-Sulpiride
(RS)-(+/-)-sulpiride
(inverted question mark)-Sulpiride
Abilit
Aiglonyl
Alimoral
Allphar Brand of Sulpiride
Almirall Brand of Sulpiride
Areu Brand of Sulpiride
Arminol
Bosnyl (TN)
Calmoflorine
Centrum Brand of Sulpiride
Championyl
Coolspan
Darleton
Deponerton
Desisulpid
Desitin Brand of Sulpiride
Desmenat
Digton
Dobren
Dogmatil
Dogmatil (TN)
Dogmatyl
Dogmatyl (TN)
Dolmatil
Dolorgiet Brand of Sulpiride
Dresent
Eglonil
Eglonyl
Eglonyl (TN)
Ekilid
Enimon
Equilid
Erempharma Brand of Sulpiride
Eusulpid
Fardalan
Fidelan
Fumouzer Brand of Sulpiride
Guastil
Hennig Brand of Sulpiride
Hexal Brand of Sulpiride
Hoechst Brand of Sulpiride
Hormosan Brand of Sulpiride
Isnamide
Krewel Brand of Sulpiride
Kylistro
Lebopride
Levobren
Levopraid
Levosulpirida
Levosulpirida [INN-Spanish]
Levosulpiride [INN]
Levosulpiridum
Levosulpiridum [INN-Latin]
Lisopiride
Magnetic resonance imaging sulpiride
Mariastel
Meresa
Meresa (TN)
Miradol
Mirbanil
Misulvan
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
Neogama
Neuraxpharm (TN)
Norestran
Normum
Nufarol
Omiryl
Omperan
Ozoderpin
Pharmacia Brand of Sulpiride
Pontiride
Psicocen
Psicofarma Brand of Sulpiride
Pyrikappl
Pyrkappl
R. D. 1403
R.D. 1403
RD 1403
RV-12309
Ratiopharm (TN)
Restful
Rosemont Brand of Sulpiride
S 8010
Sanofi Synthelabo Brand of Sulpiride
Sanofi-Synthelabo Brand of Sulpiride
Sernevin
Splotin
Spyfarma Brand of Sulpiride
Stamonevrol
Sulp
Sulperide
Sulpirid
Sulpirid (TN)
Sulpirida
Sulpirida [INN-Spanish]
Sulpiride
Sulpiride (JP15/USAN/INN)
Sulpiride [USAN:INN:BAN:JAN]
Sulpiridum
Sulpiridum [INN-Latin]
Sulpiryd (TN)
Sulpitil
Sulpivert
Sulpor
Sulpride
Sulpyrid
Suprium
Sursumid
Synedil
Tepavil
Uriach Brand of Sulpiride
Valirem
Vertigo Meresa
Vertigo neogama
Vertigo-Meresa
Vertigo-neogama
Zemorcon
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H23N3O4S
|
||||||||||||||||||
| Molecular Weight |
341.433
|
||||||||||||||||||
| Canonical SMILES |
CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
BGRJTUBHPOOWDU-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
15676-16-1
23672-07-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00209, Carbonic anhydrase
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Cell-based Assay
Clinical Information about the Compound